Medicare Enrolled
Dr. Bania Calero, MD
Family Medicine · Conyers, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Calero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Calero?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Calero
Dr. Bania Calero is a family medicine specialist in Conyers, GA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Calero performed 501 Medicare services across 392 unique beneficiaries.
Between the years covered by Open Payments, Dr. Calero received a total of $5,615 from 36 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Calero is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ 501 Medicare services
$5,615 industry payments
Medicare Practice Summary
Medicare Utilization ↗501
Medicare services
Bottom 43% in GA for family medicine
392
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
137 | $75 | $360 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $58 | $248 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
38 | $15 | $47 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
32 | $10 | $40 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
32 | $125 | $397 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
26 | $10 | $64 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $75 | $282 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $107 | $452 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $31 | $57 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
17 | $72 | $219 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
16 | $2 | $12 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
13 | $50 | $120 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
13 | $282 | $1,095 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
13 | $31 | $57 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,615
Total received (2018-2024)
Avg $802/year across 7 years
Top 12% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
233
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,945 (70.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,670 (29.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,699
2023
$1,338
2022
$456
2021
$1,453
2020
$91
2019
$449
2018
$129
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$247
ABBVIE INC.
$210
Lilly USA, LLC
$197
GlaxoSmithKline, LLC.
$159
PFIZER INC.
$145
Abbott Laboratories
$112
AstraZeneca Pharmaceuticals LP
$107
Astellas Pharma US Inc
$102
Xeris Pharmaceuticals, Inc.
$87
SHIELD THERAPEUTICS INC
$78
Otsuka America Pharmaceutical, Inc.
$57
Dynavax Technologies Corporation
$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Bayer Healthcare Pharmaceuticals Inc.
$30
Actelion Pharmaceuticals US, Inc.
$28
Dexcom, Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Phathom Pharmaceuticals, Inc.
$17
Exact Sciences Corporation
$14
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
Biohaven Pharmaceuticals, Inc.
$1,320
Lilly USA, LLC
$412
Xeris Pharmaceuticals, Inc.
$373
PFIZER INC.
$369
Novo Nordisk Inc
$359
AbbVie, Inc.
$350
Amgen Inc.
$315
GlaxoSmithKline, LLC.
$285
ABBVIE INC.
$244
Abbott Laboratories
$221
AstraZeneca Pharmaceuticals LP
$197
AbbVie Inc.
$155
Astellas Pharma US Inc
$102
Otsuka America Pharmaceutical, Inc.
$100
SHIELD THERAPEUTICS INC
$78
Dexcom, Inc.
$64
Exact Sciences Corporation
$56
Bayer HealthCare Pharmaceuticals Inc.
$52
Janssen Pharmaceuticals, Inc
$48
Shield Therapeutics Inc
$46
Bayer Healthcare Pharmaceuticals Inc.
$45
SANOFI-AVENTIS U.S. LLC
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Mylan Specialty L.P.
$35
Dynavax Technologies Corporation
$35
Merck Sharp & Dohme LLC
$34
Novartis Pharmaceuticals Corporation
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Genentech USA, Inc.
$30
Merck Sharp & Dohme Corporation
$28
Actelion Pharmaceuticals US, Inc.
$28
Kowa Pharmaceuticals America, Inc.
$26
Biohaven Pharmaceutical Holding Company Ltd.
$24
Phathom Pharmaceuticals, Inc.
$17
Aytu BioScience, Inc
$15
Amarin Pharma Inc.
$12
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ANORO · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · CHANTIX · COMIRNATY · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · FARXIGA · FREESTYLE FREEDOM LITE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · Heplisav-B · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LYRICA · Livalo · MOUNJARO · NURTEC ODT · Natesto · OPSUMIT · Otezla · Ozempic · PREVNAR - 13 · PROCLAIM · QULIPTA · REXULTI · Repatha · Rybelsus · SHINGRIX · Skyrizi · TOUJEO · TRELEGY ELLIPTA · Tresiba · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Xofluza · YUPELRI · Yupelri · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Family medicine physicians within 10 mi
898
Per 100K population
952.4
County median income
$72,349
Nearest hospital
PIEDMONT ROCKDALE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Calero is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of GA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Calero experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Calero performed 137 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Calero receive payments from pharmaceutical companies?
Yes. Dr. Calero received a total of $5,615 from 36 companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Calero's costs compare to other family medicine physicians in Conyers?
Dr. Calero's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Calero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Conyers
Browse family medicine physicians in Conyers ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Xeris Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Xeris Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology